Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Catalent Inc
(NY:
CTLT
)
60.98
+1.32 (+2.21%)
Official Closing Price
Updated: 7:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Catalent Inc
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 31, 2023
It's time for another busy day of trading as we go over the biggest pre-market stock movers worth watching on Tuesday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
October 30, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 19, 2023
Via
Benzinga
Weight-Loss Drug Boom Has Another Ripple Effect - Rapid Growth Expected In Fill-Finish Market
October 09, 2023
Contract drug manufacturers are investing billions of dollars in expanding or constructing facilities that fill the injection pens used for weight-loss drugs like Novo Nordisk A/S's (NYSE: NVO)...
Via
Benzinga
Analyst Ratings for Catalent
September 29, 2023
Via
Benzinga
15 Analysts Have This to Say About Catalent
August 31, 2023
Via
Benzinga
Catalent Earnings Preview
August 28, 2023
Via
Benzinga
CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 27, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Flee to Healthcare Stocks if Recession Rears its Head?
September 20, 2023
In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends.
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Catalent Appoints David McErlane as Biologics Segment Leader
September 18, 2023
From
Catalent, Inc.
Via
Business Wire
Catalent Receives NYSE Notice Regarding Late Form 10-K Filing
September 15, 2023
From
Catalent, Inc.
Via
Business Wire
3 Debt-Ridden S&P 500 Stocks to Sell Before It’s Too Late
September 07, 2023
With debt getting more expensive, it’s become easier to recommend unloading these three S&P 500 stocks now.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Catalent, Inc. to Present at September Investor Conferences
September 07, 2023
From
Catalent, Inc.
Via
Business Wire
Barron's Weekend Stock Picks: Globalstar Satellites, Catalent And Dell's Delightful Destiny
September 02, 2023
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
September 05, 2023
Via
Benzinga
Why Catalent Stock Zoomed 12% Higher This Week
September 01, 2023
A strong earnings report and a clutch of analyst price target hikes will do that.
Via
The Motley Fool
Catalent's Activist Board Presence To Boost Operational Recovery, Analyst Says
August 30, 2023
Tuesday, Catalent Inc (NYSE: CTLT) reported Q4 adjusted EPS of $0.09, missing the consensus of $0.10, with sales of $1.07 billion, down 17% Y/Y, slightly above the
Via
Benzinga
RBC Capital Maintains Outperform Rating for Catalent: Here's What You Need To Know
August 30, 2023
Via
Benzinga
Why Catalent Stock Surged Nearly 5% Higher Today
August 29, 2023
Fourth-quarter performance that wasn't too disappointing, plus a settlement with an activist investor, brought some bulls back to the company's shares.
Via
The Motley Fool
Workhorse Fails to Get Enough Votes to Increase WKHS Stock Count
August 29, 2023
Workhorse (WKHS) stock is on the move Tuesday after the company failed to get shareholder approval to increase its share count.
Via
InvestorPlace
Can a New CFO Save Canoo (GOEV) Stock?
August 29, 2023
Canoo (GOEV) stock is getting a boost on Tuesday as investors react to the company naming its new Chief Financial Officer.
Via
InvestorPlace
ORCL Stock Alert: Can AI Hype Really Boost Oracle 20%?
August 29, 2023
Oracle (ORCL) stock is in the news Tuesday as UBS analyst Karl Keirstead makes a bull case for the information technology company's shares.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
China's Response To Shield Economy From Real Estate Storm, Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle, Google Collaborates With Nvidia In AI Expansion: Today's Top Stories
August 29, 2023
Bloomberg China Takes Drastic Measures To Shield Economy From Real Estate Storm
Via
Benzinga
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Economy
Catalent (CTLT) Stock Gains on Elliott Deal
August 29, 2023
Catalent (CTLT) stock is getting a boost on Tuesday after the company reached an agreement with Elliott Investment Management.
Via
InvestorPlace
Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings
August 29, 2023
Catalent Inc (NYSE: CTLT), valued at around $8 billion, has finalized a deal with activist investor Elliott Investment Management.
Via
Benzinga
Exposures
COVID-19
Catalent Announces Governance Enhancements and New Initiatives to Drive Value
August 29, 2023
From
Catalent, Inc.
Via
Business Wire
Catalent, Inc. Reports Preliminary Fourth Quarter and Fiscal 2023 Results
August 29, 2023
From
Catalent, Inc.
Via
Business Wire
Wegovy's Massive Demand: Novo Nordisk CEO Expresses Full Confidence In Catalent Amid Manufacturing Hurdles
August 25, 2023
Novo Nordisk A/S's (NYSE: NVO) CEO, Lars Fruergaard Jorgensen, expressed confidence in Catalent Inc's (NYSE: CTLT) capability to rectify its manufacturing issues related to its
Via
Benzinga
Why Novo Nordisk Stock Was Racing Higher on Wednesday
August 23, 2023
When you have a hot item on the market, it's wise to ramp up production.
Via
The Motley Fool
One Is Not Enough For Famed Weight Loss Drug: Novo Nordisk Taps Thermo Fisher To Ramp Up Wegovy Production
August 23, 2023
Novo Nordisk A/S (NYSE: NVO) has reportedly enlisted the services of Thermo Fisher Scientific Inc (NYSE: TMO) as its second contract manufacturer for its highly sought-after
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.